Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
4
×
detroit blog main
detroit top stories
fda
4
×
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
clinical trials
eli lilly
pfizer
allergan
astrazeneca
biogen
chinook therapeutics
deals
What
bio
roundup
cancer
days
drugs
alliance
annual
appetite
ash
august
barcelona
biotech
black
bread
bristol
busy
butter
buy
buyout
calls
cash
changing
clinical
color
conference
crispr
december's
decisions
devices
diabetes
diamond’s
eli
esmo
european
fda
giant
grabbed
growing
hasn’t
hold
Language
unset
Current search:
glaxosmithkline
×
fda
×
" new york top stories "
×
" bristol-myers squibb "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More